Marta Tapia

Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies

A. Lluch, P. Eroles, B. Bermejo, 2023, Cancers.

Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts

E. Mittendorf, T. King, A. Prat, 2023, Cancer.